Min Seon Kim

Min Seon Kim

Auto-generated profile, based on publicly available information

Min Seon Kim

Department of Radiology, Seoul National University Bundang Hospital, Seongnam, South Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
SSSung Oh Song
Sung Oh Song
MKMin Seon Kim
Min Seon Kim
KLKyung Hee Lee
Kyung Hee Lee
SCSuk Jin Choi
Suk Jin Choi
송성오, et al. J Korean Soc Radiol. 2021 Jul;82:e91. https://doi.org/10.3348/jksr.2020.0181

14 July 2021 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
WKWang Hyon Kim
Wang Hyon Kim
MKMin Seon Kim
Min Seon Kim
JKJun Ho Kim
Jun Ho Kim
KLKyung Hee Lee
Kyung Hee Lee
JLJung Hwan Lee
Jung Hwan Lee
김왕현, et al. J Korean Soc Radiol. 2021 Jul;82:e100. https://doi.org/10.3348/jksr.2020.0213

7 May 2021 in Medicine
Verified
Journal Article
Open access
JKJeong Keyom Kim
Jeong Keyom Kim
MKMin Seon Kim
Min Seon Kim
KLKyung Hee Lee
Kyung Hee Lee
RLRo Woon Lee
Ro Woon Lee
LKLucia Kim
Lucia Kim
Introduction: The relationship between chronic empyema and malignant tumors, most of which are lymphoma, has been recognized for many decades. Sarcomatoid carcinoma associated with chronic empyema is extremely rare, may metastasize to other organs in the early stage, and rapidly progresses to death. As far as we know, this was the first case report on sarcomatoid carcinoma associated chronic empyema. The patient's main concerns and important clinical findings: A 59-year-old man presented to our hospital with a 9-year history of chronic empyema and a chief complaint of left chest wall pain for 5 months. The diagnostic contrast-enhanced computed tomography (CT) showed a large irregular soft tissue mass located on the left lower hemithorax at the margin of the empyema cavity extending to the adjacent chest wall and lung parenchyma. In addition, CT revealed pleural and pulmonary metastases surrounded by ground glass opacity. The main diagnosis, therapeutics interventions, and outcomes: The patient underwent CT guided percutaneous core needle biopsy (PCNB). The histopathological evaluation showed carcinomatous proliferation of pleomorphic spindle cells with extensive necrosis. Immunohistochemically, tumor cells were positive for cytokeratin and vimentin. The final histopathological diagnosis was sarcomatoid carcinoma underlying chronic empyema. The tumors showed rapid progression on serial simple radiography. Palliative treatments were performed, but the patient still developed severe dyspnea and died shortly after on day 16. Conclusion: Sarcomatoid carcinoma can occur very rarely as a complication of chronic empyema, and is more aggressive than usual. Early detection of developing malignancy during the follow-up of chronic empyema is an important factor for patient prognosis.

18 August 2025 in Current Medical Imaging
Verified
Journal Article
Open access
YLYeonhee Lee
Yeonhee Lee
SJSowon Jang
Sowon Jang
MKMinseon Kim
Minseon Kim
JKJunghoon Kim
Junghoon Kim
Introduction: Unlike its well-established role in lung cancer staging, positron emission tomography /computed tomography (PET/CT)'s role in guiding lung biopsies remains unclear and underutilized, despite its potential to distinguish metabolically active regions from areas of necrosis or fibrosis within lesions. Objective: This study aims to assess the diagnostic efficacy of PET/CT-aided versus conventional CT-guided lung biopsy by comparing the incidences of non-diagnostic results, false results, and complications. Methods: Studies comparing PET/CT-aided and conventional CT-guided lung biopsy were identified through an intensive search of PubMed, Embase, and the Cochrane Library. Data on nondiagnostic results, false results, and complications were extracted. Risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Results: Seven studies involving 1,661 procedures were included. PET/CT-aided lung biopsy significantly reduced nondiagnostic results compared to conventional CT-guided biopsy (2.8% vs. 9.1%; pooled RR: 0.38, 95% CI: 0.20–0.70, P = 0.002). False results were also significantly fewer in the PET/CT-aided group (6.5% vs. 17.0%; pooled RR: 0.48, 95% CI: 0.35–0.65, P < 0.001). There was no statistically significant difference in overall complication rates (28.1% vs. 32.5%; pooled RR: 0.92, 95% CI: 0.77–1.10, P = 0.352), while PET/CT-aided biopsy showed a slight tendency toward fewer major complications (0.9% vs. 1.7%; pooled RR: 0.67, 95% CI: 0.30–1.44, P = 0.303). Conclusion: PET/CT-aided CT-guided lung biopsy offers advantages over conventional CT-guided lung biopsy by significantly reducing nondiagnostic and false results, without significant differences in the risk of complications.

1 June 2011
Verified
Book Chapter
Closed access
MSMi-Seon Shin
Mi-Seon Shin
HCHyukki Chang
Hyukki Chang
CNCherl NamKoong
Cherl NamKoong
JPJoong Yeol Park
Joong Yeol Park
KLKi Up Lee
Ki Up Lee
MKMin-Seon Kim
Min-Seon Kim
Article published by the Endocrine Society Article published by the Endocrine Society

24 October 2025 in Journal of Thoracic Imaging
Verified
Journal Article
Closed access
SJSowon Jang
Sowon Jang
MKMinseon Kim
Minseon Kim
Jeong Sub LeeJeong Sub Lee
Jeong Sub Lee
SYSung Hyun Yoon
Sung Hyun Yoon
JKJunghoon Kim
Junghoon Kim
KLKyung Won Lee
Kyung Won Lee
Purpose: To develop and validate a nomogram to predict hemoptysis after percutaneous transthoracic needle biopsy (PTNB) by integrating clinical and radiologic data, facilitating pre-biopsy decision-making. Materials and Methods: This single-center, retrospective cohort study included 1383 patients who underwent 1389 PTNB procedures between 2020 and 2022. The participants were randomly allocated to the training and validation cohorts. Logistic regression was performed to discern the independent predictors of hemoptysis within the clinical and radiologic variables. A nomogram was developed based on pre-biopsy variables obtained before the biopsy, and its performance was subsequently evaluated. The goodness of fit of the nomogram was compared with that of another model, which integrated pre-biopsy and post-biopsy variables. Results: Among the 1389 procedures, hemoptysis was observed in 128 (9.2%) cases. Current smoking status, lesion size of <25 mm, consolidation-type lesions, presence of the computed tomography bronchus sign, and perilesional vascularity were independent predictors of PTNB-related hemoptysis. The nomogram based on the pre-biopsy variables showed fair discrimination abilities (area under the receiver operating characteristic curve = 0.79 and 0.76 in the training and validation cohorts, respectively) and strong calibration agreement in the training and validation cohorts. The model fit was good in both cohorts ( P = 0.41 and 0.55 in the training and validation cohorts, respectively). No significant difference was observed in the model fit between the pre-biopsy nomogram and the model incorporating pre-biopsy and post-biopsy variables ( P = 0.88). Conclusion: The proposed nomogram utilizing pre-biopsy variables could predict hemoptysis before PTNB.